Original ArticleRecovery of lung function following a pulmonary exacerbation in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor☆
Under an Elsevier user license
open archive
Keywords
Cystic fibrosis
Pulmonary exacerbations
Ivacaftor
Cystic fibrosis transmembrane conductance regulator
Pulmonary function
Cited by (0)
- ☆
Presented at the 36th European Cystic Fibrosis Society (ECFS) Conference, Lisbon, Portugal, 12–15 June 2013.
© 2017 European Cystic Fibrosis Society. Published by Elsevier B.V.